Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the feasibility of intranasal ketamine for adequate sedation of children undergoing minor procedures in the Emergency Department. An intranasal dose of 10mg/kg will be used in patients requiring procedural sedation. The investigators hypothesize that this dose of intranasal ketamine will be able to provide adequate sedation and analgesia for the physician to successfully complete the planned diagnostic or therapeutic intervention (Pediatr Emer Care 2012;28: 767-70). The primary endpoint will be successful sedation, as defined by the ability to complete the planned procedure without rescue medication, which includes re-dosing of the same medication.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03067974
Study type Interventional
Source University of Arizona
Contact
Status Terminated
Phase Early Phase 1
Start date September 21, 2017
Completion date January 22, 2019

See also
  Status Clinical Trial Phase
Completed NCT04701008 - Efficacy of Ketamine in Post Anesthesia Recovery Room
Recruiting NCT04490031 - Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 4
Completed NCT00486902 - Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients? N/A
Completed NCT03525912 - Neuropsychiatric and Cardiovascular Side Effects in Ketamine Analgesic Infusions N/A
Completed NCT03979105 - Cardiovascular Safety After Continuous Ketamine Infusion